Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,953 | 144 | 86.9% |
| Travel and Lodging | $894.93 | 4 | 13.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | $1,217 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $745.32 | 15 | $0 (2024) |
| Allergan, Inc. | $728.03 | 13 | $0 (2022) |
| Alcon Vision LLC | $611.69 | 12 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $402.17 | 11 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $365.75 | 4 | $0 (2024) |
| ABBVIE INC. | $295.97 | 18 | $0 (2024) |
| Oyster Point Pharma, Inc. | $233.45 | 3 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $201.74 | 5 | $0 (2024) |
| Dompe US, Inc. | $200.61 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,869 | 44 | Alcon Vision LLC ($328.12) |
| 2023 | $1,073 | 29 | Mallinckrodt Hospital Products Inc. ($231.41) |
| 2022 | $870.03 | 21 | Mallinckrodt Hospital Products Inc. ($170.76) |
| 2021 | $15.80 | 1 | Novartis Pharmaceuticals Corporation ($15.80) |
| 2020 | $95.79 | 6 | Alcon Vision LLC ($29.76) |
| 2019 | $2,121 | 23 | Johnson & Johnson Surgical Vision, Inc. ($1,186) |
| 2018 | $475.33 | 12 | Regeneron Healthcare Solutions, Inc. ($122.11) |
| 2017 | $327.66 | 12 | Alcon Laboratories Inc ($110.24) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Musculoskeletal | ||||||
| 11/22/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Ophthalmology | ||||||
| 11/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: EYE CARE | ||||||
| 11/14/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $116.10 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $119.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: EYE CARE | ||||||
| 10/18/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $149.46 | General |
| 10/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: EYE CARE | ||||||
| 10/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/03/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: EYE CARE | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $0.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: EYE CARE | ||||||
| 08/12/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Ophthalmology | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/23/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: OPTOMETRY | ||||||
| 07/16/2024 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $82.49 | General |
| Category: Ophthalmology | ||||||
| 07/02/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: EYE CARE | ||||||
| 06/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/26/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,985 | 2,678 | $702,365 | $258,808 |
| 2022 | 16 | 2,049 | 2,798 | $732,050 | $253,858 |
| 2021 | 16 | 2,174 | 2,971 | $766,320 | $288,971 |
| 2020 | 17 | 1,969 | 2,671 | $695,430 | $270,108 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 16 | 104 | $104,000 | $71,480 | 68.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 612 | 654 | $88,290 | $51,781 | 58.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 89 | 127 | $254,000 | $50,183 | 19.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 286 | 520 | $52,000 | $31,391 | 60.4% |
| 92134 | Imaging of retina | Office | 2023 | 158 | 267 | $33,375 | $7,350 | 22.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 28 | 30 | $35,100 | $7,237 | 20.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 28 | 92 | $27,600 | $7,115 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 104 | $10,400 | $6,119 | 58.8% |
| 92250 | Photography of the retina | Office | 2023 | 205 | 213 | $29,820 | $5,539 | 18.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 122 | 124 | $12,400 | $4,899 | 39.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 45 | 45 | $7,875 | $3,477 | 44.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 107 | 184 | $18,400 | $3,432 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $8,740 | $3,324 | 38.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 124 | 129 | $16,125 | $3,117 | 19.3% |
| J3590 | Unclassified biologics | Office | 2023 | 14 | 28 | $1,960 | $1,270 | 64.8% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 19 | 19 | $2,280 | $1,095 | 48.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 91 | 147 | $294,000 | $58,519 | 19.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 633 | 660 | $89,100 | $50,358 | 56.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 15 | 66 | $66,000 | $47,554 | 72.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 308 | 588 | $58,800 | $33,861 | 57.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 43 | 44 | $53,100 | $11,108 | 20.9% |
| 92134 | Imaging of retina | Office | 2022 | 168 | 299 | $37,375 | $8,209 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 118 | $11,800 | $7,567 | 64.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 32 | 83 | $24,900 | $6,998 | 28.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 68 | 68 | $11,900 | $6,014 | 50.5% |
About Dr. Mark Law, MD
Dr. Mark Law, MD is a Ophthalmology healthcare provider based in Newark, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275536237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Law, MD has received a total of $6,848 in payments from pharmaceutical and medical device companies, with $1,869 received in 2024. These payments were reported across 148 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,953).
As a Medicare-enrolled provider, Law has provided services to 8,177 Medicare beneficiaries, totaling 11,118 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Newark, OH
- Active Since 05/24/2005
- Last Updated 11/24/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1275536237
Products in Payments
- Premium Cataract IOLs (Device) $1,186
- ACTHAR (Biological) $402.17
- LUMIGAN (Drug) $333.19
- EYLEA HD (Biological) $330.12
- EYLEA (Biological) $293.09
- XIIDRA (Drug) $273.12
- OZURDEX (Drug) $237.16
- TYRVAYA (Drug) $233.45
- RESTASIS (Drug) $225.18
- VYZULTA (Drug) $224.34
- XDEMVY (Drug) $201.74
- VUITY (Drug) $187.10
- OXERVATE (Drug) $181.67
- Rhopressa (Drug) $170.77
- Kahook Dual Blade (Device) $155.12
- MIEBO (Drug) $143.56
- TEPEZZA (Biological) $135.59
- ORA (Device) $135.13
- AcrySof IQ VIVITY (Device) $123.67
- EYLEA AFLIBERCEPT INJECTION (Biological) $122.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Newark
Robert Fechtner, Md, MD
Ophthalmology — Payments: $432,599
Dr. Albert Khouri, Md, MD
Ophthalmology — Payments: $394,020
Dr. David Chu, Md, MD
Ophthalmology — Payments: $177,269
Dr. Marco Zarbin, Md, Phd, MD, PHD
Ophthalmology — Payments: $139,479
Dr. Roger Turbin, Md, MD
Ophthalmology — Payments: $5,303
Dr. Elliot Davidoff, Md, MD
Ophthalmology — Payments: $3,015